SymBio Pharmaceuticals
4582.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 48.93% |
| Cantor Fitzgerald Europe | 7.35% |
| YOSHIDA FUMINORI | 6.35% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 2
| Heights Capital Management, Inc. | 4.18% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| YOSHIDA FUMINORI2026-08-05 · amended | 6.35% | no change |
| YOSHIDA FUMINORI2026-08-05 · amended | 6.35% | new |
| Cantor Fitzgerald Europe2026-03-04 | 7.35% | -1.91pp |
| Cantor Fitzgerald Europe2026-03-02 · amended | 9.26% | -4.42pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 55.34% | -0.91pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 56.25% | -1.15pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 57.40% | +50.96pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 6.44% | -20.17pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 26.61% | +2.79pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 23.82% | -3.73pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 27.55% | +1.64pp |
| Evolution Capital Management LLC2025-08-19 · amended | 0.00% | no change |
| Evo Fund2025-08-19 · amended | 25.91% | -2.39pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.